Summary
The pharmacokinetics of a single oral dose (400 mg) of carbamazepine and sodium valproate were compared in peptic ulcer patients before and after four weeks of a therapeutic course of either cimetidine (1 g/day, n=6 subjects) or ranitidine (300 mg/day, n=6 subjects). There was a small (up to 20%) but statistically significant decrease in oral clearance of carbamazepine after cimetidine treatment. A similar fall in sodium valproate clearance in five cimetidine-treated patients was accompanied by a significantly prolonged elimination half-life. No such trends were demonstrated during ranitidine treatment. Since both anticonvulsants are partly metabolized by hepatic mixed function oxidases, an inhibition by cimetidine at this level may be responsible for the observed impairment of clearance. Thus a potentially important clinical interaction may occur in patients taking anticonvulsants and cimetidine concurrently.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bertilsson L (1978) Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet 3: 128–143
Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS (1982) Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 24: 267–303
Gibaldi M, Perrier D (1982) In: Pharmacokinetics, 2nd edn. Marcel Dekker, New York Basel, pp 271–287
Grasela DM, Rocci ML Jr (1983) Inhibition of carbamazepine metabolism by cimetidine. Clin Pharmacol Ther 33: 252
Gugler R, von Unruh GE (1980) Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 5: 67–83
Levy RH, Koch KM (1982) Drug interactions with valproic acid. Drugs 24: 543–556
Mihaly GW, Cockbain S, Jones DB, Hanson RG, Smallwood RA (1982) High-pressure liquid chromatographic determination of cimetidine in plasma and urine. J Pharm Sci 71: 590–592
Mihaly GW, Drummer OH, Marshall A, Smallwood RA, Louis WJ (1980) High-pressure liquid chromatographic determination of ranitidine. J Pharm Sci 69: 1155–1157
Mihaly GW, Phillips JA, Louis WJ, Vajda FJ (1977) Measurement of carbamazepine and its epoxide metabolite by high-performance liquid chromatography and a comparison of assay techniques for the analysis of carbamazepine. Clin Chem 23: 2283–2287
Mihaly GW, Vajda FJ, Miles JL, Louis WJ (1979) Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients. Eur J Clin Pharmacol 16: 23–29
Pelkonen O, Puurunen J (1980) The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat. Biochem Pharmacol 29: 3075–3080
Reilly PEB, Carrington LE, Winzor DJ (1983) The interaction of cimetidine with rat liver microsomes. Biochem Pharmacol 32: 831–835
Rendic S, Alebic-Kolbah T, Kajfez F, Ruf H-H (1982) Interaction of ranitidine with liver microsomes. Xenobiotica 12: 9–17
Rendic S, Kajfez F, Ruf H-H (1983) Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P450. Drug Metab Disp 11: 137–142
Rendic S, Sinjic V, Toso R, Kajfez F, Ruf H-H (1979) Interaction of cimetidine with liver microsomes. Xenobiotica 9: 555–564
Somogyi A, Gugler R (1982) Drug interactions with cimetidine. Clin Pharmacokinet 7: 23–41
Telerman-Toppet N, Duret M, Coers C (1981) Cimetidine interactions with carbamazepine. Ann Int Med 94: 544
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Webster, L.K., Mihaly, G.W., Jones, D.B. et al. Effect of cimetidine and ranitidine on carbamazepine and sodium valproate pharmacokinetics. Eur J Clin Pharmacol 27, 341–343 (1984). https://doi.org/10.1007/BF00542172
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542172